Myelodysplastic syndromes trials in Argentina

1 trial · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Lower Risk Myelodysplastic Syndromes (LR-MDS) Who Need Regular Blood Transfusions

  Where

  Buenos Aires, Córdoba, Rosario

  Age

  18 years and over

  People

  300 worldwide

  Run by

  Takeda

  See details and how to joinNCT07422480 · EU 2025-523544-12-00